Cr2O3/Al-Al2O3 composite catalysts for hydrocarbons dehydrogenation prepared from aluminum nanopowder

Aluminum nanopowder (10–150 nm) was treated hydrothermally in mild conditions (60–95 °C, at atmospheric pressure), and an aluminum-alumina composite with high porosity and specific surface area was obtained. Cr2O3/Al-Al2O3 catalysts were prepared using the aluminum-alumina composite by impregnation techniques and tested in dehydrogenation of C4-hydrocarbons. It was shown that aluminum-alumina composites had high chemical and phase purity, specific surface area of 150–350 m2/g and the average pore size of 8–13 nm, that is favorable for application as support for catalysts. Cr2O3/Al-Al2O3 catalysts had high activity and selectivity in dehydrogenation of n- and i-butane (conversion of 44–80 mol.% and selectivity >85% at temperatures of 540–610 °C), that is comparable ones for commercial catalysts for CATOFIN, STAR processes

AI is a viable alternative to high throughput screening: a 318-target study

: High throughput screening (HTS) is routinely used to identify bioactive small molecules. This requires physical compounds, which limits coverage of accessible chemical space. Computational approaches combined with vast on-demand chemical libraries can access far greater chemical space, provided that the predictive accuracy is sufficient to identify useful molecules. Through the largest and most diverse virtual HTS campaign reported to date, comprising 318 individual projects, we demonstrate that our AtomNet® convolutional neural network successfully finds novel hits across every major therapeutic area and protein class. We address historical limitations of computational screening by demonstrating success for target proteins without known binders, high-quality X-ray crystal structures, or manual cherry-picking of compounds. We show that the molecules selected by the AtomNet® model are novel drug-like scaffolds rather than minor modifications to known bioactive compounds. Our empirical results suggest that computational methods can substantially replace HTS as the first step of small-molecule drug discovery

Customs Regulation of Cross-Border Movement of Goods Containing Intellectual Property Objects in the Context of Eurasian Integration

A condition for the effective integration of Eurasian Economic Union member states economies is creating a set of mechanisms for the use of intellectual property objects in modern circumstances. With significant intellectual potential existing in the EAEU countries, the process of commercialization and use of intellectual property objects is not carried out sufficiently. Considering the main purpose of the Union's functioning, this problem has to be solved comprehensively and consistently. The article presents the main results of study of customs regulation system of goods containing intellectual property objects crossborder movement in the context of Eurasian integration. It is noted that the violation of intellectual property rights occurs not only among competing companies as a plagiarism or industrial espionage, but also within framework of agreements concluded between copyright holders and users of intellectual property rights. The EAEU countries cooperate and organize interaction of authorized bodies also to form a unified system of intellectual property rights protection within the EAEU, SCO, BRICS, as well as the WTO. In order to improve the system of customs control of goods containing intellectual property objects, constant adjustments and modernization of methods for controlling the intellectual property objects movement across the customs border of the EAEU are required to ensure the maximum possible protection of intellectual property holders from illegal actions of third parties. The publication was made within the framework of the state assignment for 2021 No. 0851-2020-003

Luminescent materials on the basis of yttrium oxide and yttrium aluminum garnet used for photodynamic therapy

Finely-dispersed phosphors of Y2O3:Eu and Y3Al5O12:Eu have been synthesized with the help of Pechini method and the method of self-propagating high-temperature synthesis (SHS). During the synthesis of phosphors on the basis of Y2O3 carried out with Pechini method the size of crystallites increases with the enlargement of concentration of yttrium, but it decreases when the method of SHS is applied. The structure of phosphors on the basis of Y3Al5O12 (YAG) is strongly amorphized. This fact agrees with the data of XRD and with the prevalence of the band with λmax = 613 nm in the spectra of this phosphor. The enlargement of yttrium concentration in it promotes the amorphisation of yttrium aluminum garnet and the decrease of a crystal phase content. The sample of Y3Al5O12:Eu synthesized with Pechini method has the maximum intensity, while in conditions of excitement with “high-level” X-ray radiation which corresponds to the radiation of industrial medical X-ray apparatus, the phosphor of Y2O3:Eu synthesized with the help of SHS showed the largest intensity. Colloid solutions prepared with the use of the samples synthesized by SHS method revealed a higher steadiness and a lower disposition to the sedimentation process. The samples of Y2O3:Eu phosphor possessing the smallest size of particles and the highest intensity of X-ray luminescence are the most suitable for the creation of pharmacological drugs used for photodynamic therapy

Luminescent materials on the basis of yttrium oxide and yttrium aluminum garnet used for photodynamic therapy

Finely-dispersed phosphors of Y2O3:Eu and Y3Al5O12:Eu have been synthesized with the help of Pechini method and the method of self-propagating high-temperature synthesis (SHS). During the synthesis of phosphors on the basis of Y2O3 carried out with Pechini method the size of crystallites increases with the enlargement of concentration of yttrium, but it decreases when the method of SHS is applied. The structure of phosphors on the basis of Y3Al5O12 (YAG) is strongly amorphized. This fact agrees with the data of XRD and with the prevalence of the band with λmax = 613 nm in the spectra of this phosphor. The enlargement of yttrium concentration in it promotes the amorphisation of yttrium aluminum garnet and the decrease of a crystal phase content. The sample of Y3Al5O12:Eu synthesized with Pechini method has the maximum intensity, while in conditions of excitement with “high-level” X-ray radiation which corresponds to the radiation of industrial medical X-ray apparatus, the phosphor of Y2O3:Eu synthesized with the help of SHS showed the largest intensity. Colloid solutions prepared with the use of the samples synthesized by SHS method revealed a higher steadiness and a lower disposition to the sedimentation process. The samples of Y2O3:Eu phosphor possessing the smallest size of particles and the highest intensity of X-ray luminescence are the most suitable for the creation of pharmacological drugs used for photodynamic therapy

Cr2O3/Al-Al2O3 composite catalysts for hydrocarbons dehydrogenation prepared from aluminum nanopowder

Aluminum nanopowder (10–150 nm) was treated hydrothermally in mild conditions (60–95 °C, at atmospheric pressure), and an aluminum-alumina composite with high porosity and specific surface area was obtained. Cr2O3/Al-Al2O3 catalysts were prepared using the aluminum-alumina composite by impregnation techniques and tested in dehydrogenation of C4-hydrocarbons. It was shown that aluminum-alumina composites had high chemical and phase purity, specific surface area of 150–350 m2/g and the average pore size of 8–13 nm, that is favorable for application as support for catalysts. Cr2O3/Al-Al2O3 catalysts had high activity and selectivity in dehydrogenation of n- and i-butane (conversion of 44–80 mol.% and selectivity >85% at temperatures of 540–610 °C), that is comparable ones for commercial catalysts for CATOFIN, STAR processes